Allena Pharmaceuticals Inc. (NASDAQ: ALNA) open the trading on February 25, 2021, with a bit cautious approach as it glided -7.73% to $1.67. During the day, the stock rose to $1.8199 and sunk to $1.62 before settling in for the price of $1.81 at the close. Taking a more long-term approach, ALNA posted a 52-week range of $0.52-$3.39.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -24.20%. This publicly-traded company’s shares outstanding now amounts to $36.26 million, simultaneously with a float of $26.17 million. The organization now has a market capitalization sitting at $81.85 million. At the time of writing, stock’s 50-day Moving Average stood at $1.6258, while the 200-day Moving Average is $1.5417.
Allena Pharmaceuticals Inc. (ALNA) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Allena Pharmaceuticals Inc.’s current insider ownership accounts for 0.90%, in contrast to 40.50% institutional ownership. According to the most recent insider trade that took place on Dec 17, this organization’s President and CEO sold 103,116 shares at the rate of 1.36, making the entire transaction reach 140,238 in total value, affecting insider ownership by 144,816. Preceding that transaction, on Dec 17, Company’s Chief Financial Officer sold 68,550 for 1.36, making the whole transaction’s value amount to 93,228. This particular insider is now the holder of 121,272 in total.
Allena Pharmaceuticals Inc. (ALNA) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 9/29/2020 suggests? It has posted -$0.22 earnings per share (EPS) not meeting the forecaster’s viewpoint (set at -$0.21) by -$0.01. This company achieved a return on equity of -142.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
Allena Pharmaceuticals Inc.’s EPS decrease for this current 12-month fiscal period is -24.20% and is forecasted to reach -0.74 in the upcoming year.
Allena Pharmaceuticals Inc. (NASDAQ: ALNA) Trading Performance Indicators
Let’s observe the current performance indicators for Allena Pharmaceuticals Inc. (ALNA). It’s Quick Ratio in the last reported quarter now stands at 8.00. The Stock has managed to achieve an average true range (ATR) of 0.20.
In the same vein, ALNA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.27, a figure that is expected to reach -0.19 in the next quarter, and analysts are predicting that it will be -0.74 at the market close of one year from today.
Technical Analysis of Allena Pharmaceuticals Inc. (ALNA)
[Allena Pharmaceuticals Inc., ALNA] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 27.06% While, its Average True Range was 0.1842.
Raw Stochastic average of Allena Pharmaceuticals Inc. (ALNA) in the period of the previous 100 days is set at 31.48%, which indicates a major rise in contrast to 17.39% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 83.58% that was lower than 87.66% volatility it exhibited in the past 100-days period.